MYD88 and Alzheimer disease: Fasudil inhibits the expression of TLR4, MyD88, and NF-κB; moreover, it promotes microglia transition to the M2 phenotype in AD mice through the TLR4/MyD88/NF-κB pathway (Guo et al., 2020).